Table 3.
Signature NPM1 (MFI)* |
Signature NPM1 + Signature AML/ETO, inv(16) ADE (MFI)* |
|||||||
---|---|---|---|---|---|---|---|---|
NPM1-WT | NPM1-Mut | NPM1-WT | NPM1-Mut | Inv16-A | Inv16-D | Inv16-E | AML1/ETO | |
No RNA | 87 | 87 | 42 | 81 | 86 | 64 | 43 | 57 |
100% OCI-AML3 | 13,019 | 12,604 | 9745 | 10,719 | 110 | 67 | 83 | 64 |
HL-60 + 10% OCI-AML3 | 11,523 | 11,839 | 9745 | 10,263 | 65 | 44 | 77 | 92 |
HL-60 + 1% OCI-AML3 | 14,023 | 9097 | 10,579 | 7623 | 134 | 78 | 52 | 37 |
HL-60 + 0.1% OCI-AML3 | 14,025 | 4455 | 9881 | 3408 | 25 | 73 | 30 | 36 |
HL-60 + 0.01% OCI-AML3 | 13,745 | 1088 | 10,166 | 785 | 159 | 81 | 81 | 74 |
100% HL-60 | 12,465 | 159 | 9236 | 77 | 2 | 66 | 24 | 17 |
HL-60 + 2E+07 copies | 10,980 | 12,416 | 10,388 | 11,638 | 97 | 87 | 102 | 144 |
HL-60 + 2E+06 copies | 10,245 | 10,718 | 9108 | 10,432 | 115 | 134 | 127 | 97 |
HL-60 + 2E+05 copies | 11,593 | 8566 | 10,564 | 8151 | 83 | 87 | 100 | 57 |
HL-60 + 2E+04 copies | 11,511 | 4158 | 10,044 | 3033 | 112 | 79 | 140 | 82 |
HL-60 + 2E+03 copies | 10,588 | 866 | 10,129 | 664 | 107 | 122 | 77 | 97 |
HL-60 + 2E+02 copies | 11,287 | 322 | 10,352 | 190 | 88 | 104 | 78 | 91 |
Mut, mutant; WT, wild-type.
Values above the cutoff are in bold.